BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 17192738)

  • 1. Multiple intravesical instillations of low-dose resiniferatoxin in the treatment of refractory interstitial cystitis.
    Peng CH; Kuo HC
    Urol Int; 2007; 78(1):78-81. PubMed ID: 17192738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of intravesical Resiniferatoxin (RTX) on lower urinary tract symptoms, urodynamic parameters, and quality of life of patients with urodynamic increased bladder sensation.
    Apostolidis A; Gonzales GE; Fowler CJ
    Eur Urol; 2006 Dec; 50(6):1299-305. PubMed ID: 16697519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple intravesical instillation of low-dose resiniferatoxin is effective in the treatment of detrusor overactivity refractory to anticholinergics.
    Kuo HC
    BJU Int; 2005 May; 95(7):1023-7. PubMed ID: 15839924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravesical resiniferatoxin for the treatment of interstitial cystitis: a randomized, double-blind, placebo controlled trial.
    Payne CK; Mosbaugh PG; Forrest JB; Evans RJ; Whitmore KE; Antoci JP; Perez-Marrero R; Jacoby K; Diokno AC; O'Reilly KJ; Griebling TL; Vasavada SP; Yu AS; Frumkin LR;
    J Urol; 2005 May; 173(5):1590-4. PubMed ID: 15821499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravesical vanilloids and neurogenic incontinence: ten years experience.
    Lazzeri M; Spinelli M; Zanollo A; Turini D
    Urol Int; 2004; 72(2):145-9. PubMed ID: 14963356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intravesical instillation of resiniferatoxin for the patients with interstitial cystitis].
    Takahashi S; Yanase M; Inoue R; Ichihara K; Masumori N; Tsukamoto T; Igawa Y; Nishizawa O
    Hinyokika Kiyo; 2006 Dec; 52(12):911-3. PubMed ID: 17252971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic effect of multiple resiniferatoxin intravesical instillations in patients with refractory detrusor overactivity: a randomized, double-blind, placebo controlled study.
    Kuo HC; Liu HT; Yang WC
    J Urol; 2006 Aug; 176(2):641-5. PubMed ID: 16813911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of intravesical resiniferatoxin for anticholinergic treatment refractory detrusor overactivity due to nonspinal cord lesions.
    Kuo HC
    J Urol; 2003 Sep; 170(3):835-9. PubMed ID: 12913711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeated intravesical onabotulinumtoxinA injections are effective in treatment of refractory interstitial cystitis/bladder pain syndrome.
    Kuo HC
    Int J Clin Pract; 2013 May; 67(5):427-34. PubMed ID: 23574103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anesthetic management of patients with interstitial cystitis during intravesical resiniferatoxin therapy].
    Komura M; Kuroiwa M; Numazawa K; Yamada T; Hoka S
    Masui; 2005 Feb; 54(2):149-52. PubMed ID: 15747509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sexual function is a determinant of poor quality of life for women with treatment refractory interstitial cystitis.
    Nickel JC; Tripp D; Teal V; Propert KJ; Burks D; Foster HE; Hanno P; Mayer R; Payne CK; Peters KM; Kusek JW; Nyberg LM;
    J Urol; 2007 May; 177(5):1832-6. PubMed ID: 17437831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A real-life multicentre clinical practice study to evaluate the efficacy and safety of intravesical chondroitin sulphate for the treatment of interstitial cystitis.
    Nickel JC; Egerdie B; Downey J; Singh R; Skehan A; Carr L; Irvine-Bird K
    BJU Int; 2009 Jan; 103(1):56-60. PubMed ID: 18778342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized controlled trial of intravesical bacillus calmette-guerin for treatment refractory interstitial cystitis.
    Mayer R; Propert KJ; Peters KM; Payne CK; Zhang Y; Burks D; Culkin DJ; Diokno A; Hanno P; Landis JR; Madigan R; Messing EM; Nickel JC; Sant GR; Warren J; Wein AJ; Kusek JW; Nyberg LM; Foster HE;
    J Urol; 2005 Apr; 173(4):1186-91. PubMed ID: 15758738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravesical resiniferatoxin for patients with neurogenic detrusor overactivity.
    Watanabe T; Yokoyama T; Sasaki K; Nozaki K; Ozawa H; Kumon H
    Int J Urol; 2004 Apr; 11(4):200-5. PubMed ID: 15028097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical evidence suggests repeated intravesical application of botulinum toxin A injections may improve treatment efficacy of interstitial cystitis/bladder pain syndrome.
    Shie JH; Liu HT; Wang YS; Kuo HC
    BJU Int; 2013 Apr; 111(4):638-46. PubMed ID: 22943596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective, randomized, double-blind study of safety and tolerability of intravesical resiniferatoxin (RTX) in interstitial cystitis (IC).
    Chen TY; Corcos J; Camel M; Ponsot Y; Tu le M
    Int Urogynecol J Pelvic Floor Dysfunct; 2005; 16(4):293-7. PubMed ID: 15818465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term results of amitriptyline treatment for interstitial cystitis.
    Hertle L; van Ophoven A
    Aktuelle Urol; 2010 Jan; 41 Suppl 1():S61-5. PubMed ID: 20094958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravesical hyaluronic acid for interstitial cystitis/painful bladder syndrome: a comparative randomized assessment of different regimens.
    Lai MC; Kuo YC; Kuo HC
    Int J Urol; 2013 Feb; 20(2):203-7. PubMed ID: 22925498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of C afferent fibers and monitoring of intravesical resiniferatoxin therapy for patients with idiopathic detrusor overactivity.
    Yokoyama T; Nozaki K; Fujita O; Nose H; Inoue M; Kumon H
    J Urol; 2004 Aug; 172(2):596-600. PubMed ID: 15247740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravesical Bacillus Calmette-Guerin for treatment of refractory interstitial cystitis.
    Aghamir SM; Mohseni MG; Arasteh S
    Urol J; 2007; 4(1):18-23. PubMed ID: 17514606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.